AGATHE : A tool for personalized rehabilitation of cognitive functions based on simulated activities of daily living
Fiche du document
- handle: 10985/8465
- hal: hal-01061264
- doi: 10.1016/j.irbm.2013.01.005
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.irbm.2013.01.005
Ce document est lié à :
http://hdl.handle.net/10985/8465
info:eu-repo/semantics/OpenAccess
Sujets proches
Individuals (Persons) People People Man Humanity (Human beings) Human race Mankind Homo sapiens Humankind Humans Cerebrum MindCiter ce document
Evelyne Klinger et al., « AGATHE : A tool for personalized rehabilitation of cognitive functions based on simulated activities of daily living », HAL-SHS : sciences de l'information, de la communication et des bibliothèques, ID : 10.1016/j.irbm.2013.01.005
Métriques
Partage / Export
Résumé
Every year, tens of thousands of people fall victim to one of invalidating neurological pathologies. Acquired brain injury leads to cognitive impairment and heavy loss of autonomy. Rehabilitation interventions are needed to enable people to recover capacity and return to Instrumental Activities of Daily Living (iADL), such as grocery shopping. Unfortunately, the resources made available in cognitive rehabilitation are insufficient for the growing needs of victims of brain damage. The goal of the AGATHE project is to develop a tool that will provide therapists with an innovative means of dealing with cognitive rehabilitation and offer patients customized rehabilitation sessions, on the basis of simulated iADL. AGATHE fits into accessibility prospects of the tool (for everyone, everywhere and anywhere) and reduction of the cost of rehabilitation. AGATHE allows the strengthening and diversification of skills and expertise of the project's clinical and research partners as well as the opening of a new application field to the technology of the industrial partners. Initial tests of the AGATHE tool have been performed among therapists and patients after brain injury in order to validate usability issues. Perspective of efficacy trials has been identified and development projects are explored.